Summary
3M Company reported a significant loss for the third quarter of 2023, primarily driven by substantial charges related to legal settlements. Net sales decreased by 3.6% year-over-year to $8.31 billion. The company recorded a net loss attributable to 3M of $2.075 billion, or a loss of $3.74 per diluted share. This compares unfavorably to a net income of $3.859 billion, or earnings of $6.77 per diluted share, in the prior year's third quarter. The significant charges include a $4.2 billion pre-tax charge for the Combat Arms Earplugs litigation settlement and a $10.3 billion pre-tax charge for the PFAS-related public water systems settlement. Excluding these "special items," adjusted earnings per diluted share were $2.68, a decrease from the adjusted $2.60 in the prior year, reflecting both volume declines in certain segments and the impact of ongoing restructuring actions. The company continues to navigate challenging market conditions, particularly in its Consumer and Transportation & Electronics segments, while making progress on its strategic initiatives, including the planned spin-off of its Health Care business. Despite the reported net loss, the company generated $4.7 billion in cash flow from operations and $3.4 billion in free cash flow for the first nine months of 2023, an increase from the prior year, driven by effective working capital management. 3M also maintained its quarterly dividend of $1.50 per share. The company's liquidity remains strong, with a newly amended revolving credit facility and substantial cash reserves. Investors should closely monitor the progress and impact of the company's significant litigation settlements and its ongoing strategic portfolio adjustments.
Financial Highlights
53 data points| Revenue | $6.27B |
| Cost of Revenue | $3.72B |
| Gross Profit | $2.55B |
| SG&A Expenses | $5.42B |
| Operating Expenses | $9.37B |
| Operating Income | -$3.10B |
| Interest Expense | $304.00M |
| Net Income | -$2.08B |
| EPS (Basic) | $-3.74 |
| EPS (Diluted) | $-3.74 |
| Shares Outstanding (Basic) | 554.30M |
| Shares Outstanding (Diluted) | 554.30M |
Key Highlights
- 1Net sales for Q3 2023 were $8.31 billion, down 3.6% year-over-year, reflecting broad-based declines across most business segments.
- 23M reported a net loss attributable to 3M of $2.075 billion ($3.74 per diluted share) for Q3 2023, a significant reversal from a net income of $3.859 billion ($6.77 per diluted share) in Q3 2022.
- 3The company recorded substantial pre-tax charges totaling approximately $14.5 billion for major legal settlements: $4.2 billion for Combat Arms Earplugs litigation and $10.3 billion for the PFAS public water systems settlement.
- 4Excluding special items, adjusted earnings per diluted share were $2.68 in Q3 2023, a slight increase from $2.60 in Q3 2022, but impacted by lower sales volumes and restructuring costs.
- 5Cash flow from operations for the first nine months of 2023 was $4.7 billion, up from $3.7 billion in the prior year, indicating strong operational cash generation despite the reported net loss.
- 6Free cash flow for the first nine months of 2023 was $3.4 billion, an increase from $2.4 billion in the comparable period of 2022.
- 73M announced a quarterly dividend of $1.50 per share, maintaining its commitment to shareholder returns and marking its 65th consecutive year of dividend increases.